Antibody-based targeting of the tumor vasculature.

Antibody-based targeting of the tumor vasculature. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Antibody-based targeting of the tumor vasculature. Abstract Text:

Christoph Schliemann,Dario Neri,Christoph Schliemann,Dario Neri,Christoph Schliemann,Dario Neri,

Conventional cytotoxic therapies of cancer often suffer from a lack of specificity, leading to a poor therapeutic index and considerable toxicities to normal organs. An elegant way to overcome the disadvantages of conventional tumor therapy is the selective delivery of therapeutics to the tumor site by their conjugation to a carrier molecule specific for a tumor-associated molecular marker. Markers expressed on the tumor's vasculature represent particularly attractive targets for a site-specific pharmacodelivery due to their inherent accessibility for blood-borne agents and the various therapeutic options that they allow, ranging from intraluminal blood coagulation to the recruitment of immune cells. In this review, we will outline advances in the preclinical and clinical evaluation of antibody-based vascular targeting agents, describe technologies for the discovery of novel vascular targets and discuss future prospects for vascular targeting applications.

Antibody-based targeting of the tumor vasculature. Publishing Authors By Initials

C Schliemann,D Neri,C Schliemann,D Neri,C Schliemann,D Neri,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Antibody-based targeting of the tumor vasculature. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Biochimica et biophysica acta

VOLUME: 1776

Page Numbers: 175-92

Journal Abbreviation:

ISSN: 0006-3002

DAY: 25

MONTH: 08

YEAR: 2007

Antibody-based targeting of the tumor vasculature. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 217513

Antibody-based targeting of the tumor vasculature. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Antibody-based targeting of the tumor vasculature. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Antibody-based targeting of the tumor vasculature.

AFFILIATION: Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Wolfgang-Pauli-Strasse 10, HCI G396, 8093 Zürich, Switzerland.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Biochim Biophys Acta

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Antibody-based targeting of the tumor vasculature Related Publications

• A 3-D CAD Tool for CT Colonography.
• A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo.
• A monoclonal antibody prevents aggregation of the NBD1 domain of the cystic fibrosis transmembrane conductance regulator.
• A perceptually lossless, model-based, texture compression technique.
• A unique case of reversion to normal size of a maternal premutation FMR1 allele in a normal boy.
• Acute generalized exanthematous pustulosis induced by pentoxifylline.
• Antepartum death of one uniovular twin.
• Anti-chemokine therapy for inflammatory diseases.
• Antibody-based targeting of the tumor vasculature.
• Congenital nodular lesion of the anterior thorax in a child.
• Disgerminoma ovarii--treatment and prognosis.
• Fast-scale adaptive changes of directional tuning in fly tangential cells are explained by a static nonlinearity.
• Glucosinolates in Diplotaxis and Eruca leaves: Diversity, taxonomic relations and applied aspects.
• HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome.
• Horner's syndrome in a patient with cervical sympathetic chain schwannoma.
• Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis.
• Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus (MPPH): report of a new case.
• Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.
• Oral-facial-digital syndromes: review and diagnostic guidelines.
• Pedunculated nodule on an infant's face.
• Possible impacts of Hg and PAH contamination on benthic foraminiferal assemblages: an example from the Sicilian coast, central Mediterranean.
• Recurrent calcified cutaneous nodule of the perianal region.
• The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.
• Verrucous psoriasis in a patient with chronic C hepatitis treated with interferon.
• Wolf-Hirschhorn syndrome-associated chromosome changes are not mediated by olfactory receptor gene clusters nor by inversion polymorphism on 4p16.
• [Further studies on the photosensitizing properties of some phenothiazine derivatives. I. Promazine, chlorpromazine, promethazine.]
• [Future plans of the Department of Health and Social Welfare for the assistance to the states at the northern border of Mexico]
• [Hepatic iron, irondepletion and answer to the therapy with peg-Interferon and Ribavirin in chronic hepatitis C. Pilot study]
• [New technic with Viadril.]
• [Not Available.]